Your session is about to expire
← Back to Search
Smoking Cessation and Health & Wellness for Acute Coronary Syndrome
This trial will test whether a single, integrated treatment that targets both depressed mood and smoking is more effective than usual care in reducing post-acute coronary syndrome mortality.
- Acute Coronary Syndrome
- Tobacco Use
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You are currently getting help for feeling sad or trying to quit smoking.You are between 18 and 75 years old.You have difficulty with understanding and making decisions.You have a serious mental illness that would make it hard for you to take part in the study, or you have thoughts of harming yourself.You are not expected to live for more than 6 months, according to a risk calculator.You have been diagnosed with acute coronary syndrome and have been in the hospital in the past 30 days.You smoked at least one cigarette per day before being hospitalized.
- Group 1: BAT-CS
- Group 2: Smoking Cessation and Health & Wellness
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Which population would be best suited to participate in this experiment?
"For this trial, 324 individuals aged 18 to 75 with a recent diagnosis of acute coronary syndrome are required. These participants must also possess the following attributes: fluency in English, smoking history of at least 1 cigarette per day prior to hospitalization, inpatient status, access to or willingness to use a study issued cell phone and agreement for consenting all trial procedures including potential quitting from smoking upon discharge."
Is the enrollment process for this clinical research still open?
"Indeed, clinicaltrials.gov has verified that this trial is actively searching for volunteers to join their study. This experiment was initially posted on January 29th 2018 and the latest update occurred on August 2nd 2022."
Is eligibility for this research endeavor limited to persons aged 60 and over?
"The age range of eligible patients for this study is between 18 years old and 75 years old."
What is the projected enrolment size of this research endeavor?
"Affirmative. The details hosted on clinicaltrials.gov suggest that this experiment, which was first introduced to the public on 29th January 2018 is currently in need of enrolment. A total of 324 patients are required from 1 medical facility."
What objectives does this experiment seek to achieve?
"This clinical trial will run for 12 months with the main objective of evaluating Depression Symptoms. Secondary objectives include testing Blood Bio-markers (HDL, LDL, High Sensitivity C-reactive protein and Fibrinogen), determining Resting Systolic and Diastolic Blood Pressure levels, as well as assessing Treatment Acceptability through a Client Satisfaction Questionnaire."
Share this study with friends